major objective of the CardioCell consortium is to retrieve basic
science knowledge about cardiomyocyte progenitors and development
and adult cardiomyocyte progenitors to develop new strategies for
cardiomyocyte replacement therapies for ischemic heart disease.
The new knowledge generated from the CardioCell project will both
contribute to significant improvements in the prevention and treatment
of cardiovascular diseases in Europe and help to maintain European
competitiveness in this field of research.
SIGN UP FOR NEWS AND UPDATES
positions are available in:
- Early cardiac progenitors
- Cardiomyocyte physiology
- Adult cardiac progenitors